The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.

Li, Q., Wang, Y., Sun, Q., Knopf, J., Herrmann, M., Lin, L., et al. (2022). Immune response in COVID-19: what is next?. CELL DEATH AND DIFFERENTIATION, 29(6), 1107-1122 [10.1038/s41418-022-01015-x].

Immune response in COVID-19: what is next?

Jiang J.;Piacentini M.;Melino S.;Melino G.;
2022-01-01

Abstract

The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.
2022
Pubblicato
Rilevanza internazionale
Review
Esperti anonimi
Settore BIO/10 - BIOCHIMICA
Settore BIOS-07/A - Biochimica
English
COVID-19 Vaccines
Humans
Immunity, Innate
Pandemics
SARS-CoV-2
COVID-19
Li, Q., Wang, Y., Sun, Q., Knopf, J., Herrmann, M., Lin, L., et al. (2022). Immune response in COVID-19: what is next?. CELL DEATH AND DIFFERENTIATION, 29(6), 1107-1122 [10.1038/s41418-022-01015-x].
Li, Q; Wang, Y; Sun, Q; Knopf, J; Herrmann, M; Lin, L; Jiang, J; Shao, C; Li, P; He, X; Hua, F; Niu, Z; Ma, C; Zhu, Y; Ippolito, G; Piacentini, M; Est...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Melino S 2022 ijms-23-08452.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 2.72 MB
Formato Adobe PDF
2.72 MB Adobe PDF Visualizza/Apri
Melino S Qing Li 2022 CDD .pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 4.49 MB
Formato Adobe PDF
4.49 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/307537
Citazioni
  • ???jsp.display-item.citation.pmc??? 58
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 76
social impact